99 related articles for article (PubMed ID: 10074360)
1. Tryptophan B27 in the relaxin-like factor (RLF) is crucial for RLF receptor-binding.
Büllesbach EE; Schwabe C
Biochemistry; 1999 Mar; 38(10):3073-8. PubMed ID: 10074360
[TBL] [Abstract][Full Text] [Related]
2. Synthetic cross-links arrest the C-terminal region of the relaxin-like factor in an active conformation.
Büllesbach EE; Schwabe C
Biochemistry; 2004 Jun; 43(25):8021-8. PubMed ID: 15209497
[TBL] [Abstract][Full Text] [Related]
3. The "hot wires" of the relaxin-like factor (Insl3).
Schwabe C; Büllesbach EE
Ann N Y Acad Sci; 2009 Apr; 1160():93-8. PubMed ID: 19416166
[TBL] [Abstract][Full Text] [Related]
4. The mode of interaction of the relaxin-like factor (RLF) with the leucine-rich repeat G protein-activated receptor 8.
Büllesbach EE; Schwabe C
J Biol Chem; 2006 Sep; 281(36):26136-43. PubMed ID: 16844694
[TBL] [Abstract][Full Text] [Related]
5. Shortened insulin analogues: marked changes in biological activity resulting from replacement of TyrB26 and N-methylation of peptide bonds in the C-terminus of the B-chain.
Záková L; Barth T; Jirácek J; Barthová J; Zórad S
Biochemistry; 2004 Mar; 43(8):2323-31. PubMed ID: 14979729
[TBL] [Abstract][Full Text] [Related]
6. Effects of side-chain characteristics on stability and oligomerization state of a de novo-designed model coiled-coil: 20 amino acid substitutions in position "d".
Tripet B; Wagschal K; Lavigne P; Mant CT; Hodges RS
J Mol Biol; 2000 Jul; 300(2):377-402. PubMed ID: 10873472
[TBL] [Abstract][Full Text] [Related]
7. Solution structure of a conformationally restricted fully active derivative of the human relaxin-like factor.
Büllesbach EE; Hass MA; Jensen MR; Hansen DF; Kristensen SM; Schwabe C; Led JJ
Biochemistry; 2008 Dec; 47(50):13308-17. PubMed ID: 19086273
[TBL] [Abstract][Full Text] [Related]
8. Design, synthesis and pharmacological evaluation of cyclic mimetics of the insulin-like peptide 3 (INSL3) B-chain.
Shabanpoor F; Bathgate RA; Hossain MA; Giannakis E; Wade JD; Hughes RA
J Pept Sci; 2007 Feb; 13(2):113-20. PubMed ID: 17120268
[TBL] [Abstract][Full Text] [Related]
9. Structure of human insulin-like peptide 5 and characterization of conserved hydrogen bonds and electrostatic interactions within the relaxin framework.
Haugaard-Jönsson LM; Hossain MA; Daly NL; Craik DJ; Wade JD; Rosengren KJ
Biochem J; 2009 May; 419(3):619-27. PubMed ID: 19178384
[TBL] [Abstract][Full Text] [Related]
10. Identification of putative agouti-related protein(87-132)-melanocortin-4 receptor interactions by homology molecular modeling and validation using chimeric peptide ligands.
Wilczynski A; Wang XS; Joseph CG; Xiang Z; Bauzo RM; Scott JW; Sorensen NB; Shaw AM; Millard WJ; Richards NG; Haskell-Luevano C
J Med Chem; 2004 Apr; 47(9):2194-207. PubMed ID: 15084118
[TBL] [Abstract][Full Text] [Related]
11. [A turning point in the knowledge of the structure-function-activity relations of elastin].
Alix AJ
J Soc Biol; 2001; 195(2):181-93. PubMed ID: 11727705
[TBL] [Abstract][Full Text] [Related]
12. Structure of the transmembrane signal initiation site of the relaxin-like factor (RLF/INSL3).
Büllesbach EE; Schwabe C
Biochemistry; 2007 Aug; 46(34):9722-7. PubMed ID: 17676766
[TBL] [Abstract][Full Text] [Related]
13. Diabetes-associated mutations in insulin: consecutive residues in the B chain contact distinct domains of the insulin receptor.
Xu B; Hu SQ; Chu YC; Huang K; Nakagawa SH; Whittaker J; Katsoyannis PG; Weiss MA
Biochemistry; 2004 Jul; 43(26):8356-72. PubMed ID: 15222748
[TBL] [Abstract][Full Text] [Related]
14. Chemical synthesis of a Zwitterhormon, insulaxin, and of a relaxin-like bombyxin derivative.
Büllesbach EE; Steinetz BG; Schwabe C
Biochemistry; 1996 Jul; 35(30):9754-60. PubMed ID: 8703947
[TBL] [Abstract][Full Text] [Related]
15. Identification of the receptor-recognition surface of bombyxin-II, an insulin-like peptide of the silkmoth Bombyx mori: critical importance of the B-chain central part.
Nagata K; Hatanaka H; Kohda D; Kataoka H; Nagasawa H; Isogai A; Ishizaki H; Suzuki A; Inagaki F
J Mol Biol; 1995 Nov; 253(5):759-70. PubMed ID: 7473750
[TBL] [Abstract][Full Text] [Related]
16. Relaxin-3, INSL5, and their receptors.
Liu C; Lovenberg TW
Results Probl Cell Differ; 2008; 46():213-37. PubMed ID: 18236022
[TBL] [Abstract][Full Text] [Related]
17. Mouse relaxin: synthesis and biological activity of the first relaxin with an unusual crosslinking pattern.
Büllesbach EE; Schwabe C
Biochem Biophys Res Commun; 1993 Oct; 196(1):311-9. PubMed ID: 8216305
[TBL] [Abstract][Full Text] [Related]
18. Specific, high affinity relaxin-like factor receptors.
Büllesbach EE; Schwabe C
J Biol Chem; 1999 Aug; 274(32):22354-8. PubMed ID: 10428805
[TBL] [Abstract][Full Text] [Related]
19. Replacement of disulfides by amide bonds in the relaxin-like factor (RLF/INSL3) reveals a role for the A11-B10 link in transmembrane signaling.
Büllesbach EE; Schwabe C
Biochemistry; 2012 May; 51(20):4198-205. PubMed ID: 22574850
[TBL] [Abstract][Full Text] [Related]
20. C-terminus loop 13 of Na+ glucose cotransporter SGLT1 contains a binding site for alkyl glucosides.
Raja MM; Kipp H; Kinne RK
Biochemistry; 2004 Aug; 43(34):10944-51. PubMed ID: 15323554
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
